GENE ONLINE|News &
Opinion
Blog

Special
Breaking Ground in Alzheimer’s with 10 Cutting-Edge Treatments Paving the Way in 2024
2024-06-21
Merck’s KEYNOTE-522 Success; BMS Licenses PRX019, Prothena Gets $80M
2024-06-19
Advancing Healthcare Accessibility and Sustainable Development
2024-06-11
New CRISPR Method Enables Gene Edits in Cockroaches and All Insects
2024-06-11
FDA Panel Backs Eli Lilly’s Alzheimer’s Drug Donanemab, Potential Approval Expected
2024-06-10
BIO 2024 Showcases the Emergence of Taiwan’s Biotech CDMO Market
2024-06-04
Autistic Individuals at Triple Risk for Parkinson’s-Like Symptoms, Study Finds
2024-05-30
Taiwan Biotech Delegation Leads International Exchange with Phoenix Biotech Community and Mayo Clinic
2024-05-29
BIO 2024 Sets the Stage for Taiwan’s Biotech Industry to Shine
2024-05-29
New Regulatory Measures in China A First in the Fight Against Sedentary Behavior in Children
2024-05-24
Discrimination Leads to Rapid Aging, Science Shows the Detrimental Effects of this Act
2024-05-17
A New Study has Linked Treatment Resistant Depression to Body Mass Index
2024-05-16
The EU Sustainability Directive’s Influence on Pharmaceutical Supply Chains
2024-05-15
Biotech in Beauty: Engineered Skin Bacteria Designed To Treat Acne
2024-05-10
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
1 2 3 21
LATEST
APAC Leading the Industry in Adoptive Cell Therapy – Trials, Economic Growth, and Pioneering Companies
2024-06-24
Taiwan’s Biotech and Pharma Delegation: Innovations Take Center Stage at BIO 2024
2024-06-21
Merck Buys EyeBio for $3B and Shares Global Policy Perspectives During BIO in San Diego
2024-06-20
Johnson & Johnson’s Bispecific Antibodies for Atopic Dermatitis and Talks of Biotech Partnerships at BIO 2024
2024-06-20
Merck’s KEYNOTE-522 Success; BMS Licenses PRX019, Prothena Gets $80M
2024-06-19
SINBON and MAKALOT partner to drive cross-industry textile wearable adoption
2024-06-19
Pie Medical Imaging announces enrollment completion of the FASTIII clinical trial
2024-06-18
EVENT
Scroll to Top